These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1117 related articles for article (PubMed ID: 15579189)
1. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome. Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189 [TBL] [Abstract][Full Text] [Related]
2. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance. Sepilian V; Nagamani M J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109 [TBL] [Abstract][Full Text] [Related]
3. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Ardawi MS; Rouzi AA Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640 [TBL] [Abstract][Full Text] [Related]
4. Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices. Lewandowski KC; Szosland K; O'Callaghan C; Tan BK; Randeva HS; Lewinski A Mol Genet Metab; 2005 May; 85(1):61-9. PubMed ID: 15862282 [TBL] [Abstract][Full Text] [Related]
5. Adiponectin is an independent determinant of insulin resistance in women with polycystic ovary syndrome. Gulcelik NE; Aral Y; Serter R; Demir Y; Culha C Gynecol Endocrinol; 2006 Sep; 22(9):511-5. PubMed ID: 17071536 [TBL] [Abstract][Full Text] [Related]
6. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome. Pehlivanov B; Mitkov M Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711 [TBL] [Abstract][Full Text] [Related]
7. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome. Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421 [TBL] [Abstract][Full Text] [Related]
8. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome. Toscani M; Migliavacca R; Sisson de Castro JA; Spritzer PM Metabolism; 2007 Jul; 56(7):992-7. PubMed ID: 17570263 [TBL] [Abstract][Full Text] [Related]
9. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study. Singh S; Akhtar N; Ahmad J Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540 [TBL] [Abstract][Full Text] [Related]
10. Plasma visfatin levels in normal weight women with polycystic ovary syndrome. Panidis D; Farmakiotis D; Rousso D; Katsikis I; Delkos D; Piouka A; Gerou S; Diamanti-Kandarakis E Eur J Intern Med; 2008 Oct; 19(6):406-12. PubMed ID: 18848173 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of the phosphoprotein enriched in diabetes gene product (Ped/pea-15) in women with polycystic ovary syndrome. Savastano S; Orio F; Palomba S; Cascella T; Manguso F; Lupoli GA; Formisano P; Lombardi G; Colao A; Beguinot F; Valentino R Clin Endocrinol (Oxf); 2007 Oct; 67(4):557-62. PubMed ID: 17590172 [TBL] [Abstract][Full Text] [Related]
12. The adiponectin-to-leptin ratio in women with polycystic ovary syndrome: relation to insulin resistance and proinflammatory markers. Xita N; Papassotiriou I; Georgiou I; Vounatsou M; Margeli A; Tsatsoulis A Metabolism; 2007 Jun; 56(6):766-71. PubMed ID: 17512308 [TBL] [Abstract][Full Text] [Related]
13. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome. Diamanti-Kandarakis E; Katsikis I; Piperi C; Alexandraki K; Panidis D Clin Endocrinol (Oxf); 2007 Jan; 66(1):103-9. PubMed ID: 17201808 [TBL] [Abstract][Full Text] [Related]
14. [Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome]. Yang XF; Ren FR; Guo SP Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):261-3. PubMed ID: 16759463 [TBL] [Abstract][Full Text] [Related]
15. Endothelial dysfunction in PCOS: role of obesity and adipose hormones. Carmina E; Orio F; Palomba S; Longo RA; Cascella T; Colao A; Lombardi G; Rini GB; Lobo RA Am J Med; 2006 Apr; 119(4):356.e1-6. PubMed ID: 16564785 [TBL] [Abstract][Full Text] [Related]
16. Gender differences in association of plasma adiponectin with obesity reflect resultant insulin resistance in non-diabetic Japanese patients with schizophrenia. Matsuda Y; Tanioka T; Yoshioka T; Nagano T; Hiroi T; Yoshikawa K; Okabe K; Nagamine I; Takasaka Y Psychiatry Clin Neurosci; 2005 Jun; 59(3):266-73. PubMed ID: 15896219 [TBL] [Abstract][Full Text] [Related]
17. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome. Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948 [TBL] [Abstract][Full Text] [Related]
18. Association of the T45G polymorphism in exon 2 of the adiponectin gene with polycystic ovary syndrome: role of Delta4-androstenedione. Panidis D; Kourtis A; Kukuvitis A; Farmakiotis D; Xita N; Georgiou I; Tsatsoulis A Hum Reprod; 2004 Aug; 19(8):1728-33. PubMed ID: 15178661 [TBL] [Abstract][Full Text] [Related]
19. In vitro evidence that hyperglycemia stimulates tumor necrosis factor-alpha release in obese women with polycystic ovary syndrome. González F; Rote NS; Minium J; Kirwan JP J Endocrinol; 2006 Mar; 188(3):521-9. PubMed ID: 16522732 [TBL] [Abstract][Full Text] [Related]
20. [Correlations between adipocytokines and insulin resistance in women with polycystic ovary syndrome]. Li X; Li X; Huang HY; Ma D; Zhu MW; Lin JF Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(37):2607-10. PubMed ID: 20137676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]